XML 92 R76.htm IDEA: XBRL DOCUMENT v3.25.1
COMMITMENTS - DSI Agreement (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Jul. 15, 2024
Jul. 01, 2020
Feb. 28, 2023
Dec. 31, 2024
Dec. 31, 2023
Disclosure of classes of share capital [line items]          
Amount held in escrow account         $ 790
Proceeds received following global termination agreement $ 9,900        
Liabilities       $ 22,726 20,978
Loss From Global Termination Agreement 2,300     (2,359)  
Restricted Cash And Cash Equivalent released. 700        
Movantik Acquisition Co, Valinor Pharma, LLC, and HCR Redhill SPV, LLC          
Disclosure of classes of share capital [line items]          
Liabilities $ 12,200        
Movantik          
Disclosure of classes of share capital [line items]          
Amount held in escrow account     $ 16,000   $ 800
Gains On Disposals Of Movantik       35,500  
Gains From The Debt Extinguishment.       20,600  
Cash Payment For Rights To Movantik Used To Determine Fair Value       $ 95,000  
Paid transition services period     9 months    
Movantik | DSI          
Disclosure of classes of share capital [line items]          
Contractual capital commitments   $ 15,100      
Payments For Commercialization Of Movantik   10,100      
Payment Commitment Assumed By HCRM   $ 5,000